Transcriptional Analysis of Murine Macrophages Infected with Different Toxoplasma Strains Identifies Novel Regulation of Host Signaling Pathways

PLoS Pathogens

Volumn 9, Issue 12, 2013, Pages 1-17

  Melo, Mariane B ^a   Nguyen, Quynh P ^a   Cordeiro, Cynthia ^a,b,c   Hassan, Musa A ^a   Yang, Ninghan ^a   McKell, Renée ^a   Rosowski, Emily E ^a   Julien, Lindsay ^a   Butty, Vincent ^a   Dardé, Marie Laure ^d,e   Ajzenberg, Daniel ^d,e   Fitzgerald, Katherine ^f   Young, Lucy H ^c   Saeij, Jeroen P J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE LIMOGES   (France)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; PHOSPHOTRANSFERASE; RETINOIC ACID INDUCIBLE PROTEIN I; ROP38; TOLL LIKE RECEPTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; FIBROBLAST; GENE; GENE CLUSTER; GRA15 GENE; HIGH THROUGHPUT SEQUENCING; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INTRACELLULAR KILLING; MACROPHAGE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; TOXOPLASMA; TOXOPLASMOSIS; TRANSCRIPTION REGULATION; VIRULENCE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; MOUSE; MULTIGENE FAMILY; PARASITOLOGY; PATHOGENICITY;

ANIMALS; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELLS; HOST-PARASITE INTERACTIONS; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MULTIGENE FAMILY; SIGNAL TRANSDUCTION; TOXOPLASMA;

EID: 84892860527     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003779     Document Type: Article

References (83)

1. Dubremetz JF, (1998) Host cell invasion by Toxoplasma gondii. Trends Microbiol 6: 27-30.
2. Hoffmann S, Batz MB, Morris JG Jr, (2012) Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot 75: 1292-1302.
3. Walker M, Zunt JR, (2005) Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 40: 1005-1015.
4. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, et al. (2008) Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2: e277.
5. Jamieson SE, Peixoto-Rangel AL, Hargrave AC, Roubaix L-Ad, Mui EJ, et al. (2010) Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun 11: 374-383.
6. Witola WH, Mui E, Hargrave A, Liu S, Hypolite M, et al. (2011) NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect Immun 79: 756-766.
7. Bela SR, Dutra MS, Mui E, Montpetit A, Oliveira FS, et al. (2012) Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii. Infect Immun 80: 4298-4308.
8. Melo MB, Jensen KD, Saeij JP, (2011) Toxoplasma gondii effectors are master regulators of the inflammatory response. Trends Parasitol 27: 487-495.
9. McLeod R, Boyer KM, Lee D, Mui E, Wroblewski K, et al. (2012) Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis 54: 1595-1605.
10. Sibley LD, Boothroyd JC, (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359: 82-85.
11. Khan A, Dubey JP, Su C, Ajioka JW, Rosenthal BM, et al. (2011) Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int J Parasitol 41: 645-655.
12. Dardé M-L, (2004) Genetic analysis of the diversity in Toxoplasma gondii. Ann Ist Super Sanita 40: 57-63.
13. Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, et al. (2006) Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis 12: 942-949.
14. Pena HFJ, Gennari SM, Dubey JP, Su C, (2008) Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int J Parasitol 38: 561-569.
15. Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, et al. (2012) Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci USA 109: 5844-5849.
16. Khan A, Miller N, Roos DS, Dubey JP, Ajzenberg D, et al. (2011) A monomorphic haplotype of chromosome Ia is associated with widespread success in clonal and nonclonal populations of Toxoplasma gondii. mBio 2: e00228-00211.
17. Khan A, Fux B, Su C, Dubey JP, Darde ML, et al. (2007) Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc Natl Acad Sci USA 104: 14872-14877.
18. Minot S, Melo MB, Li F, Lu D, Niedelman W, et al. (2012) Admixture and recombination among Toxoplasma gondii lineages explain global genome diversity. Proc Natl Acad Sci USA 109: 13458-13463.
19. Khan A, Taylor S, Ajioka JW, Rosenthal BM, Sibley LD, (2009) Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet 5: e1000404.
20. Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD, et al. (2006) Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314: 1780-1783.
21. Dubey JP, Lindsay DS, Speer CA, (1998) Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 11: 267-299.
22. Saeij JPJ, Coller S, Boyle JP, Jerome ME, White MW, et al. (2007) Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445: 324-327.
23. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, et al. (2011) Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci USA 108: 9631-9636.
24. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP, (2011) Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci USA 108: 9625-9630.
25. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, et al. (2006) A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314: 1776-1780.
26. Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, et al. (2010) Phosphorylation of Immunity-Related GTPases by a Toxoplasma gondii-Secreted Kinase Promotes Macrophage Survival and Virulence. Cell Host Microbe 8: 484-495.
27. Steinfeldt T, Konen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, et al. (2010) Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol 8: e1000576.
28. Niedelman W, Gold DA, Rosowski EE, Sprokholt JK, Lim D, et al. (2012) The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 8: e1002784.
29. Behnke MS, Fentress SJ, Mashayekhi M, Li LX, Taylor GA, et al. (2012) The Polymorphic Pseudokinase ROP5 Controls Virulence in Toxoplasma gondii by Regulating the Active Kinase ROP18. PLoS Pathog 8: e1002992.
30. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, et al. (2005) Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1: e24.
31. Rosowski EE, Saeij JP, (2012) Toxoplasma gondii Clonal Strains All Inhibit STAT1 Transcriptional Activity but Polymorphic Effectors Differentially Modulate IFNgamma Induced Gene Expression and STAT1 Phosphorylation. PLoS ONE 7: e51448.
32. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, et al. (2011) Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 208: 195-212.
33. Peixoto L, Chen F, Harb OS, Davis PH, Beiting DP, et al. (2010) Integrative Genomic Approaches Highlight a Family of Parasite-Specific Kinases that Regulate Host Responses. Cell Host Microbe 8: 208-218.
34. Ong YC, Boyle JP, Boothroyd JC, (2011) Strain-dependent host transcriptional responses to Toxoplasma infection are largely conserved in mammalian and avian hosts. PLoS ONE 6: e26369.
35. Ajzenberg D, (2012) High burden of congenital toxoplasmosis in the United States: the strain hypothesis? Clin Infect Dis 54: 1606-1607.
36. Grigg ME, Ganatra J, Boothroyd JC, Margolis TP, (2001) Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184: 633-639.
37. Ajzenberg D, (2011) Unresolved questions about the most successful known parasite. Expert Rev Anti Infect Ther 9: 169-171.
38. Demar M, Hommel D, Djossou F, Peneau C, Boukhari R, et al. (2012) Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clin Microbiol Infect 18: E221-231.
39. Carme B, Demar M, Ajzenberg D, Darde ML, (2009) Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis 15: 656-658.
40. Groh M, Faussart A, Villena I, Ajzenberg D, Carme B, et al. (2012) Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient. PLoS Negl Trop Dis 6: e1802.
41. Dardé ML, Villena I, Pinon JM, Beguinot I, (1998) Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. J Clin Microbiol 36: 324.
42. Radke JR, Donald RG, Eibs A, Jerome ME, Behnke MS, et al. (2006) Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathog 2: e105.
43. Segal E, Friedman N, Koller D, Regev A, (2004) A module map showing conditional activity of expression modules in cancer. Nat Genet 36: 1090-1098.
44. Behnke MS, Wootton JC, Lehmann MM, Radke JB, Lucas O, et al. (2010) Coordinated progression through two subtranscriptomes underlies the tachyzoite cycle of Toxoplasma gondii. PLoS ONE 5: e12354.
45. Jensen KD, Wang Y, Wojno ED, Shastri AJ, Hu K, et al. (2011) Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9: 472-483.
46. Yamamoto M, Standley D, Takashima S, Saiga H, Okuyama M, et al. (2009) A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J Exp Med.
47. Ong Y-C, Reese ML, Boothroyd JC, (2010) Toxoplasma Rhoptry Protein 16 (ROP16) Subverts Host Function by Direct Tyrosine Phosphorylation of STAT6. J Biol Chem 285: 28731-28740.
48. Takeuchi O, Akira S, (2009) Innate immunity to virus infection. Immunol Rev 227: 75-86.
49. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, et al. (2002) Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 4465-4470.
50. Saeij JP, Boyle JP, Boothroyd JC, (2005) Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol 21: 476-481.
51. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, et al. (2010) Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 26: 190-196.
52. Sergent V, Cautain B, Khalife J, Deslée D, Bastien P, et al. (2005) Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells. Infect Immun 73: 6990-6997.
53. Huber JP, Farrar JD, (2011) Regulation of effector and memory T-cell functions by type I interferon. Immunology 132: 466-474.
54. MacMicking JD, (2012) Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 12: 367-382.
55. Costa VM, Torres KC, Mendonca RZ, Gresser I, Gollob KJ, et al. (2006) Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J Immunol 177: 3193-3200.
56. Koga R, Hamano S, Kuwata H, Atarashi K, Ogawa M, et al. (2006) TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. J Immunol 177: 7059-7066.
57. Mattner J, Wandersee-Steinhauser A, Pahl A, Rollinghoff M, Majeau GR, et al. (2004) Protection against progressive leishmaniasis by IFN-beta. J Immunol 172: 7574-7582.
58. Morrell CN, Srivastava K, Swaim A, Lee MT, Chen J, et al. (2011) Beta interferon suppresses the development of experimental cerebral malaria. Infect Immun 79: 1750-1758.
59. Vigario AM, Belnoue E, Gruner AC, Mauduit M, Kayibanda M, et al. (2007) Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J Immunol 178: 6416-6425.
60. Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, et al. (2004) Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 172: 4926-4933.
61. Chessler AD, Caradonna KL, Da'dara A, Burleigh BA, (2011) Type I interferons increase host susceptibility to Trypanosoma cruzi infection. Infect Immun 79: 2112-2119.
62. Khouri R, Bafica A, Silva Mda P, Noronha A, Kolb JP, et al. (2009) IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J Immunol 182: 2525-2531.
63. Sharma S, DeOliveira RB, Kalantari P, Parroche P, Goutagny N, et al. (2011) Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 35: 194-207.
64. Haque A, Best SE, Ammerdorffer A, Desbarrieres L, de Oca MM, et al. (2011) Type I interferons suppress CD4(+) T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur J Immunol 41: 2688-2698.
65. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, et al. (2013) Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340: 207-211.
66. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, et al. (2013) Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340: 202-207.
67. Wang Y, Swiecki M, Cella M, Alber G, Schreiber RD, et al. (2012) Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection. Cell Host Microbe 11: 631-642.
68. Orellana MA, Suzuki Y, Araujo F, Remington JS, (1991) Role of beta interferon in resistance to Toxoplasma gondii infection. Infect Immun 59: 3287-3290.
69. Schmitz JL, Carlin JM, Borden EC, Byrne GI, (1989) Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. Infect Immun 57: 3254-3256.
70. Minns LA, Menard LC, Foureau DM, Darche S, Ronet C, et al. (2006) TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J Immunol 176: 7589-7597.
71. Foureau DM, Mielcarz DW, Menard LC, Schulthess J, Werts C, et al. (2010) TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii. J Immunol 184: 7022-7029.
72. Teles RM, Graeber TG, Krutzik SR, Montoya D, Schenk M, et al. (2013) Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339: 1448-1453.
73. Ferreira da Silva Mda F, Barbosa HS, Gross U, Luder CG, (2008) Stress-related and spontaneous stage differentiation of Toxoplasma gondii. Mol Biosyst 4: 824-834.
74. Jones TC, Bienz KA, Erb P, (1986) In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon. Infect Immun 51: 147-156.
75. Bougdour A, Durandau E, Brenier-Pinchart MP, Ortet P, Barakat M, et al. (2013) Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell Host Microbe 13: 489-500.
76. Brunet J, Pfaff AW, Abidi A, Unoki M, Nakamura Y, et al. (2008) Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell Microbiol 10: 908-920.
77. Molestina RE, El-Guendy N, Sinai AP, (2008) Infection with Toxoplasma gondii results in dysregulation of the host cell cycle. Cell Microbiol 10: 1153-1165.
78. Austin P, McCulloch E, Till J, (1971) Characterization of the factor in L-cell conditioned medium capable of stimulating colony formation by mouse marrow cells in culture. J Cell Physiol 77: 121-134.
79. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, et al. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7: 562-578.
80. Gotea V, Ovcharenko I, (2008) DiRE: identifying distant regulatory elements of co-expressed genes. Nucleic Acids Res 36: W133-139.
81. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
82. Roberts ZJ, Goutagny N, Perera PY, Kato H, Kumar H, et al. (2007) The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med 204: 1559-1569.
83. Korber B (2000) HIV Signature and sequence variation analysis. In: Rodrigo AG, Learn GH, editors. Computational analysis of HIV molecular sequences. Dordrecht, Netherlands: Kluwer Academic Publishers. pp. 55-72.